Funding Rounds
Airsonett

Airsonett Series B (2014, $4M)

Airsonett

Non-pharmaceutical treatment developer for allergic asthma.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $4.80M

Investors